| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | 0.22 | 0.5 |